Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India in November 2008.
It was launched as ‘Jan Aushadhi Scheme’ with the goal of making generic medications accessible to everyone at reasonable prices.
The programme was redesigned as the Pradhan Mantri Bhartiya Jan Aushadhi Yojana in 2015 and was later renamed Pradhan Mantri Bhartiya Janaushadhi Pariyojana to give the programme more momentum.
The implementing body of PMBJP is the Pharmaceuticals & Medical Devices Bureau of India (PMBI), formerly known as Bureau of Pharma PSUs of India.
The generic medications that are provided under this scheme are priced between 50% and 90% less than comparable branded medications available on the market. National Accreditation Board Laboratories (NABL) perform quality assurance testing on all medication purchased under this program.
Under this scheme, dedicated outlets known as Janaushadhi Kendras are opened to provide these generic medications at the affordable prices.
As of October 2022, 8819 Jan Aushadhi Kendras are functional across the country. By the end of March 2025, the government hopes to have 10,500 of these Kendras in operation.
Objectives of PMBJP:
Reducing patients’ out-of-pocket expenses while increasing access to high-quality medications, supplies, and surgical equipment.
To spread awareness about generic medications among the general public and refute the myth that generic drugs are of lower quality or more ineffective because they are more affordable.
To make sure that all women in India have easy access to menstruation health services.
Create jobs by enlisting individual business owners in the launch of PMBJP Kendras
In the fiscal year 2021-22, PMBI generated sales of ₹751.42 crores, which allow people to save almost ₹4500 crores.
Comments
Write Comment